Free Trial

ThermoGenesis (THMO) Competitors

ThermoGenesis logo

THMO vs. HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, KEYS, FTV, VLTO, and TER

Should you be buying ThermoGenesis stock or one of its competitors? The main competitors of ThermoGenesis include HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), Keysight Technologies (KEYS), Fortive (FTV), Veralto (VLTO), and Teradyne (TER). These companies are all part of the "measuring and control equipment" industry.

ThermoGenesis vs.

ThermoGenesis (NASDAQ:THMO) and HTG Molecular Diagnostics (NASDAQ:HTGMQ) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, dividends, analyst recommendations, profitability, valuation, risk, community ranking and media sentiment.

Company Net Margins Return on Equity Return on Assets
ThermoGenesisN/A N/A N/A
HTG Molecular Diagnostics N/A N/A N/A

ThermoGenesis has a beta of 2.47, meaning that its stock price is 147% more volatile than the S&P 500. Comparatively, HTG Molecular Diagnostics has a beta of 2.85, meaning that its stock price is 185% more volatile than the S&P 500.

ThermoGenesis has higher revenue and earnings than HTG Molecular Diagnostics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
ThermoGenesis$9.61M0.00-$17.98M-$5.14N/A
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A

In the previous week, ThermoGenesis' average media sentiment score of 0.00 equaled HTG Molecular Diagnostics'average media sentiment score.

Company Overall Sentiment
ThermoGenesis Neutral
HTG Molecular Diagnostics Neutral

ThermoGenesis received 26 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.

CompanyUnderperformOutperform
ThermoGenesisOutperform Votes
26
60.47%
Underperform Votes
17
39.53%
HTG Molecular DiagnosticsN/AN/A

5.8% of ThermoGenesis shares are owned by institutional investors. 78.0% of ThermoGenesis shares are owned by company insiders. Comparatively, 2.6% of HTG Molecular Diagnostics shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

ThermoGenesis beats HTG Molecular Diagnostics on 5 of the 6 factors compared between the two stocks.

Remove Ads
Get ThermoGenesis News Delivered to You Automatically

Sign up to receive the latest news and ratings for THMO and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

THMO vs. The Competition

MetricThermoGenesisLaboratory apparatus & furniture IndustryMedical SectorNASDAQ Exchange
Market Cap$2,000.00$109.38M$5.55B$7.86B
Dividend YieldN/AN/A5.35%4.04%
P/E RatioN/A6.0723.4418.67
Price / SalesN/A0.50367.8687.31
Price / CashN/A45.3038.1634.64
Price / BookN/A2.826.634.09
Net Income-$17.98M$18.75M$3.20B$246.93M

ThermoGenesis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
THMO
ThermoGenesis
N/AN/AN/AN/A$2,000.00$9.61M0.0040
HTGMQ
HTG Molecular Diagnostics
N/AN/AN/AN/A$0.00$6.37M0.0090
OLITW
OmniLit Acquisition
N/A$0.05
-21.3%
N/A-63.8%$0.00N/A0.003
PRENW
Prenetics Global
N/A$0.01
-12.1%
N/A+61.2%$0.00$25.56M0.001Positive News
Gap Down
QSIAW
Quantum-Si
N/A$0.45
+4.7%
N/A+52.1%$0.00$3.06M0.00150Gap Up
SMAPW
SportsMap Tech Acquisition
N/A$0.05
-24.1%
N/A+73.4%$0.00N/A0.00N/A
TT
Trane Technologies
4.4991 of 5 stars
$358.58
+3.3%
$413.69
+15.4%
+15.2%$80.43B$19.84B31.8739,000Positive News
KEYS
Keysight Technologies
4.3118 of 5 stars
$158.75
+2.7%
$184.44
+16.2%
-3.3%$27.43B$5.02B45.3615,000Insider Trade
Short Interest ↓
FTV
Fortive
4.2342 of 5 stars
$75.92
+1.5%
$87.64
+15.4%
-13.1%$25.83B$6.23B32.1718,000Positive News
VLTO
Veralto
3.6758 of 5 stars
$98.27
+0.5%
$113.50
+15.5%
+11.5%$24.33B$5.19B29.4216,000Short Interest ↓
Positive News
TER
Teradyne
4.9838 of 5 stars
$91.00
+4.0%
$121.44
+33.4%
-26.9%$14.72B$2.82B27.336,500Short Interest ↓
Positive News
Remove Ads

Related Companies and Tools


This page (NASDAQ:THMO) was last updated on 4/2/2025 by MarketBeat.com Staff
From Our Partners